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Abstract: Due to renewed interest in the cultivation and production of Italian Cannabis sativa L., we 
proposed a multi-methodological approach to explore chemically and biologically both the essential 
oil and the aromatic water of this plant. We reported the chemical composition in terms of 
cannabinoid content, volatile component, phenolic and flavonoid pattern, and color characteristics. 
Then, we demonstrated the ethnopharmacological relevance of this plant cultivated in Italy as a 
source of antioxidant compounds toward a large panel of enzymes (pancreatic lipase, α-amylase, α-
glucosidase, and cholinesterases) and selected clinically relevant, multidrug-sensible, and 
multidrug-resistant microbial strains (Staphylococcus aureus, Helicobacter pylori, Candida, and 
Malassezia spp.), evaluating the cytotoxic effects against normal and malignant cell lines. 
Preliminary in vivo cytotoxicity was also performed on Galleria mellonella larvae. The results 
corroborate the use of this natural product as a rich source of important biologically active molecules 
with particular emphasis on the role exerted by naringenin, one of the most important secondary 
metabolites. 
Keywords: Cannabis sativa L.; chromatographic analysis; essential oil; antimicrobial activity; cancer 
cell cytotoxicity; naringenin; biofilm; antioxidant activity; Galleria mellonella 
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1. Introduction 
Hemp (Cannabis sativa L.) is often indicated as the oldest known, cultivated, and used plant by 
humanity. Its wide development was facilitated by broad soil and climate adaptation, allowing a 
large geographical distribution, as well as by crop flexibility, giving textile, fiber, food, feed, and 
biosolvents as final products or intermediates for manufacturing industries. A parallel history 
involves relative plants with secondary metabolism producing cannabinoids, and particularly 
tetrahydrocannabinoids (THCs), which characterize crops for medicinal or illegal recreational use 
due to psychotropic effects and addiction. As a consequence of the longtime debate on the correct 
taxonomic level of distinction between THC-producing or non-THC-producing plants, for most of 
the 20th century, a general prohibition of hemp cultivation existed. Currently, the non-THC-
producing species of Cannabis sativa, or at least those producing a concentration lower than 0.2%, are 
usually referred to as fiber hemp, industrial hemp, and seed-oil hemp. Formerly, the maximum THC 
limit was imposed on plant cultivation in the open field and was not fixed by law with regards to 
final products such as food or nutraceuticals. The Italian Government promoted industrial hemp 
cultivation as a strategy to implement environmentally friendly crops and to contrast the loss of 
agricultural lands and green belts, as well as the desertification and the decrement of biodiversity [1]. 
In the Abruzzo region (central Italy), hemp cultivation is the object of renewed interest; both the 
surface dedicated to hemp crops and the volume of plant material produced are increasing. The 
economy of hemp crops is mainly sustained by female flower collection. This represents an 
innovative and high-value product that is used for tea infusion, to aromatize beer and other food 
products, and for nutraceutical purposes, involving extraction of important secondary metabolites 
[2]. Futura 75 cultivar was selected in France and is characterized by low THC content (< 0.2%) and 
is widely cultivated for the production of fiber and seeds, while floral buds and leaves are considered 
as waste or by-products [3,4]. In this context, the essential oil (EO) obtained via hydro-distillation 
could represent a solution for the novelty and the multipurpose applications in medicinal, cosmetic, 
and food industries, because it could be obtained as primary product from female flowers or aerial 
parts, as well as from crop by-products, such as residual green parts (leaves and stems) after flower 
collection or from female inflorescences. 
A previous study compared the composition and the antimicrobial activities of EOs obtained 
from three varieties of industrial hemp (Carmagnola, Fibranova, and Futura). Futura cultivar gave 
the highest essential oil yield and resulted in the most promising for application as an antimicrobial 
agent with a broad spectrum of activity [5]. Another comparative study was conducted on five hemp 
cultivars (Felina 34, Fedrina 74, SwissMix, Kompolti, and Secuemi) for chemical composition and 
antimicrobial activity. The most abundant compounds were found to be α-pinene, myrcene, trans-β-
ocimene, γ-terpinolene, (E)-caryophyllene, and α-humulene. The disc diffusion test revealed 
moderate antimicrobial activity which different among the cultivars [6]. 
More recently, the EO obtained from inflorescences or leaves of hemp cv. Futura 75 was 
proposed as a potential source of botanical insecticides against larvae of Spodoptera littoralis and Culex 
quinquefasciatus and against adults of Musca domestica [4]. The essential oil was also tested in a field 
trial to control the rosy apple aphid pest and was determined as an ecological alternative to the 
acetamiprid [7]. An aqueous emulsion of the essential oil (0.02–0.1%), mainly characterized by (E)-
caryophyllene (35%), β-myrcene (18%), and α-pinene (9%), induced high mortality rate when tested 
on the foxglove aphid (Aulacorthum solani Kalt.) and the two-spotted spider mite (Tetranychus urticae 
Koch) [8]. Hemp EO was also shown to fight the human-biting Asian tiger mosquito (Aedes albopictus) 
and the rice-crop invasive snail Physella acuta [9]. Increasing interest for the essential oil is confirmed 
by the increasing literature data, which could be related to its limited toxicity for mammals [10], as 
well as its low ecological impact on the environment [11]. 
Due to the increasing attention in the valorization of locally produced plants to support their 
use in the pharmaceutic, cosmetic, and food industry and to valorize the cultivation by-products, the 
EO obtained via hydro-distillation of aerial parts from C. sativa cv. Futura 75, cultivated in Italy, and 
its aromatic water were studied herein. Phytochemical investigation was performed on the terpenoid 
fraction (GC/MS), and the phenolic and flavonoid fingerprint (spectrophotometric and 
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chromatographic methods), in addition to color analysis (CIELAB parameters; see Section 2.2). The 
potential applications of the EO were investigated in a wide multidisciplinary approach for different 
biological activities, such as antioxidant and antiradical, enzyme inhibition, antimicrobial activities 
on bacteria and fungi, and a comparative cytotoxic activity on tumor and non-tumor cell lines. A 
preliminary in vivo evaluation of the toxicity was also carried out on Galleria mellonella larvae. The 
broad-spectrum investigation provided a general characterization of the EO of THC-free C. sativa and 
could be used to support its use and application in innovative and multi-target ingredients for 
medicinal, cosmetic, veterinary, agronomic, or food use. 
2. Materials and Methods 
2.1. Experimental Farm and Plant Extraction 
Two experimental fields were selected in the surroundings of Chieti, Italy (42°21′46.5′′ N 
14°05′49.2′′ E, 100 m above sea level) in the old alluvial plain of the Pescara River Valley. The climate 
is Mediterranean, with an average yearly temperature around 15 °C and mean yearly rainfall around 
750 mm. Summer can be variably dry. Total extension of the experimental crops comprises 15,000 
square meters on level ground (slope 0–5%). During the two years preceding, the farm field was 
uncultured and mowed to obtain hay. The sowings were scheduled on the last week of March 2016 
and were planned to favor the plant development during a long photoperiod and to stimulate full 
blooming in late summer. 
The selection of Futura 75 was done considering the local climatic and soil characteristics in 
relation to the evidence of the high adaptive capabilities of this variety which are useful for multi-
purpose cultivation. Selected seeds were purchased from South Hemp Tecno (Taranto, Italy) and 
certified by SOC France (Service officiel de contrôle et de certification des semences et plants) 
according to the plant variety database of the European Commission in the agricultural species list 
(position A-85, FR 8194). Soil tillage consisted of superficial ploughing followed by disc harrowing 
and final milling to prepare the sowing bed. Sowing was performed using a mechanic seeder for 
wheat, settled to obtain a final density of 50 kg of seeds/ha. The sowing was in line every 30 cm with 
10 cm between lines. No fertilizer was used and, during growth, three irrigation cycles were 
programmed (automatic irrigation system, each cycle 24–36 h, depending on soil water availability). 
Plants development was monitored weekly until the beginning of flowering, when manual collection 
of aerial parts from flowering plants was done. The collection was carried out every three days, 
starting on the first week of September up to October 2016. Immediately after harvest, the plant 
material was transferred to the laboratory for extraction (about 100 m away). Random samples were 
tested for macroscopic characteristics in order to confirm their botanical identity (done by Prof. L. 
Menghini). 
Fresh aerial parts consisting of leaves, inflorescences, and thinner residues of stem were roughly 
cropped to uniform size and accurately distributed inside the distillation chamber. The distillatory 
was a stainless-steel 12-L Clevenger-type apparatus (Albrigiluigi S.r.l., Stallavena, Italy). The 
distillation started within 5 h of plant collection in the field and was performed for no longer than 3 
h. Straightaway, the collected EOs were passed through septa with anhydrous sodium sulfate in 
order to remove water residues, before being transferred to a sealed blue glass bottle and stored in 
the dark at 4 °C until used for phytochemical and biological assays. The EO yields (%, v/w) were 
determined each time and were expressed as mean volume obtained from plant fresh weight. 
Moreover, as a by-product, the aromatic water was also characterized in our experiments to assess 
its potential economic value in the framework of a lower-waste agri-food chain. In agreement with 
“circular economy” principles, our approach could further provide innovative results for reducing 
waste load. 
2.2. Color Analysis 
CIELAB parameters (L*, a*, b*, C*ab, and hab), according to the “Commission Internationale de 
l′Eclairage”, were determined using a colorimeter X-Rite SP-62 (X-Rite Europe GmbH, Regensdorf, 
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Switzerland), equipped with a D65 illuminant and an observer angle of 10°. Color interpretation was 
based on the lightness L* (between 0, absolute black, and 100, absolute white), the greenness 
(negative) or redness (positive) a*, and the blueness (negative) or yellowness (positive) b*. The 
chroma, or saturation (C*ab) quantitatively describes the color intensity, and the hue or color angle 
(hab) is the attribute of appearance by which a color is identified according to its resemblance to red, 
yellow, green, blue, or a combination of two of these [12]. The results are reported as the mean value 
± standard deviation (SD). 
2.3. Gas Chromatography/Mass Spectrometry (GC/MS) Analysis 
The volatile component analysis was carried out using an Agilent Technologies 6850 gas 
chromatograph (Santa Clara, CA, USA) coupled with an Agilent Technologies 5975 mass 
spectrometer (Santa Clara, CA, USA), equipped with an HP-5MS capillary column (5% phenyl 95% 
methylpolysiloxane, 30 m × 0.25 mm inner diameter, film thickness 0.25 µm; Hewlett-Packard, Palo 
Alto, CA, USA). GC parameters were adjusted as follows: injector temperature, 250 °C; flow rate of 
the helium carrier gas (99.995% purity), 1.0 mL/min. The oven temperature was set at 40 °C (5 min), 
then raised to 200 °C at 5 °C/min, and maintained at this temperature for 60 min. MS parameters were 
set as follows: energy of electron ionization, 70 eV; solvent delay, 6 min; source temperature, 230 °C; 
quadrupole temperature, 150 °C; and mass scan was carried out over the 50–350 m/z range. 
The eluted compounds were identified by matching the relative mass spectra with those 
available from both a commercial database (FFNSC 3, Chromaleont srl, Messina, Italy) and online 
libraries (NIST 11, Flavor2, Scientific Instrument Services, Ringoes, NJ, USA) [13]. Kovats index (KI) 
was used as a second parameter to confirm the analyte identification. KIs were measured using a 
mixture of n-alkanes (C8–C24) in the same analytic conditions, and then compared with values 
reported in the literature and in the FFNSC 3 database. The identity of several compounds was 
confirmed through injection of standard samples available from commercial sources. The relative 
abundance of oil components was obtained by integrating the GC/MS peak areas without any further 
correction. 
2.4. Total Phenolic Acid Content 
The samples (1.0 mL) were added to 0.5 M hydrochloric acid (2 mL), 8.5% sodium hydroxide (2 
mL), and Arnow reagent (10% aqueous solution of sodium nitrite and sodium molybdate, 2 mL), and 
diluted to 10.0 mL with water. The absorbance of the test solution was measured against the blank at 
505 nm. Obtained results are reported as caffeic acid equivalents (CAE/g sample) [14]. 
2.5. Total Phenolic Content 
The total phenolic quantification was determined using the Folin–Ciocâlteu method [15]. Test 
solutions (0.25 mL) were mixed with Folin–Ciocâlteu reagent (1 mL, 1:9 v/v). After 3 min, Na2CO3 
solution (0.75 mL, 1%) was added and, after 2 h incubation at room temperature, the absorbance was 
measured at 760 nm. Results are expressed as milligrams of gallic acid equivalent per gram of sample 
(GAE/g sample). 
2.6. Total Flavonoid Content 
The total flavonoid quantification was measured using the AlCl3 method by Berk at al. (2011) 
[16]. Test solutions (1 mL) were mixed with aluminum trichloride (2% in methanol). Similarly, a blank 
was prepared (sample solution (1 mL) and methanol (1 mL)). The absorbances were recorded at 415 
nm after a 10-min incubation at room temperature. Results are expressed as milligrams of rutin 
equivalent per gram of sample (RE/g sample) [17]. 
2.7. HPLC Analysis 
All chemicals were purchased from Sigma-Aldrich (Milan, Italy), whereas HPLC-grade solvents 
were obtained from Carlo Erba Reagenti (Milan, Italy). Double-distilled water was obtained using a 
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Millipore Milli-Q Plus water treatment system (Millipore Bedford Corp., Bedford, MA, USA). HPLC 
photo diode array (PDA) phenolic patterns were established using the validated method reported in 
the literature [18]. Data are reported as means ± standard deviation of three independent 
measurements. 
3. Biological Activities 
All biochemical analyses were carried out within four weeks of the extraction process to avoid 
any deterioration of the samples. 
3.1. Radical Scavenging and Chelating Activity 
3.1.1. Free-Radical Scavenging Activity 
Each test solution (1 mL) was added to 2,2-diphenyl-1-picrylhydrazyl (DPPH) solution (4 mL, 
0.004% methanolic solution). The sample absorbance was noted at 517 nm after 30-min incubation at 
room temperature in the dark. Results are expressed as milligrams of trolox equivalent per gram of 
extract (TE/g sample) [19]. 
3.1.2. Radical Cation Scavenging Activity 
The 2,2-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+) radical cation was produced 
in situ by reacting 7 mM ABTS solution with 2.45 mM potassium persulfate and allowing the mixture 
to stand for 12–16 h in the dark at the room temperature. Firstly, ABTS solution was diluted with 
methanol to an absorbance of 0.700 ± 0.02 at 734 nm. Each test solution (1 mL) was mixed with ABTS 
solution (2 mL). The sample absorbance was noted at 734 nm after 30-min incubation at room 
temperature. Results are expressed as milligrams of trolox equivalent per gram of extract (TE/g 
extract) [20]. 
3.1.3. Evaluation of Total Antioxidant Capacity Using Phosphomolybdenum Assay 
Each test solution (0.3 mL) was mixed with 3 mL of reagent solution (0.6 M sulfuric acid, 28 mM 
sodium phosphate, and 4 mM ammonium molybdate). The sample absorbance was read at 695 nm 
after 90 min incubation at 95 °C. Results are expressed as millimoles of trolox equivalent per gram of 
dry extract (TEs/g extract) [21]. 
3.1.4. Cupric Ion Reducing (CUPRAC) Method 
Each test solution (0.5 mL) was added to reaction mixture containing CuCl2 (1 mL, 10 mM), 
neocuproine (1 mL, 7.5 mM), and NH4Ac buffer (1 mL, 1 M, pH 7.0). Similarly, a blank was prepared 
using sample solution (0.5 mL) and reaction mixture (3 mL) without CuCl2. The absorbances were 
read at 450 nm after 30 min of incubation at room temperature. Results are expressed as milligrams 
of trolox equivalent per gram of extract (TE/g extract) [22]. 
3.1.5. Ferric Reducing Antioxidant Power (FRAP) Method 
Each sample solution (0.1 mL) was added to FRAP reagent (2 mL) containing acetate buffer (0.3 
M, pH 3.6), 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ) (10 mM) in 40 mM HCl, and ferric chloride (20 mM) 
in a ratio of 10:1:1 (v/v/v). Then, the absorbance was read at 593 nm after a 30-min incubation at room 
temperature. Results are expressed as milligrams of trolox equivalent per gram of extract (TE/g 
extract) [22]. 
3.1.6. Metal Chelating Activity on Ferrous Ions 
Each test solution (2 mL) was added to FeCl2 solution (0.05 mL, 2 mM). The reaction was initiated 
by the addition of 5 mM ferrozine (0.2 mL). Similarly, a blank was prepared using test solution (2 
mL), FeCl2 solution (0.05 mL, 2 mM), and water (0.2 mL). Then, the absorbances of sample and blank 
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were noted at 562 nm after 10-min incubation at room temperature. Results are expressed as 
milligrams of ethylenediaminetetraacetic acid (EDTA) equivalent per gram of extract (EDTAE/g 
extract) [22]. 
3.2. Antimicrobial Activity 
3.2.1. Staphylococcus aureus 
3.2.1.1. Bacterial Strains and Culture Conditions 
The antimicrobial activity was evaluated on one reference strain (S. aureus American Type 
Culture Collection (ATCC) 29213) and three clinical strains (S. aureus 101 TV, S. aureus 104, and S. 
aureus 105), isolated from different sources and characterized by a different antimicrobial 
susceptibility pattern. The samples were cultured on Mueller–Hinton agar (MHA, Oxoid Ltd, 
Hampshire, UK) and on mannitol salt agar (MSA, Oxoid Ltd, Hampshire, UK). The identification of 
clinical isolates was carried out on the basis of colony morphology, Gram stain, and API® systems 
(bioMérieux, Marcy l'Etoile, France). The antimicrobial susceptibility pattern was determined using 
the Kirby–Bauer disc diffusion method [23]. The antibiotic discs (erythromycin 15 µg, tetracycline 30 
µg, netilimicin 30 µg, levofloxacin 5 µg, cefoxitin 30 µg, linezolid 10 µg, rifampicin 30 µg, and 
gentamicin 10 µg) used for susceptibility tests were supplied by Oxoid Ltd, Hampshire, UK. 
S. aureus strains were stored at −80 °C before being thawed at room temperature and plated on 
tryptic soy agar (TSA; Oxoid Ltd, Hampshire, UK). Bacteria were then grown in tryptic soy broth 
(TSB; Oxoid Ltd, Hampshire, UK) for 24 h at 37 °C under shaking conditions at 125 rpm (Innova 4300, 
New Brunswick Scientific, Edison, NJ, USA). The overnight broth cultures were resuspended in 
Mueller–Hinton broth (MHB, Oxoid Ltd, Hampshire, UK) to an optical density at 550 nm (OD550) of 
1.0 corresponding to 1.0 × 108 colony-forming units (CFU)/mL. The broth cultures were then diluted 
1:100 in MHB and used for the evaluation of the minimum inhibitory concentration (MIC) described 
below, where each well in the 96-well plate contained the bacteria at a final concentration of 1.0 × 105 
CFU/mL according to the NCCLS (National Committee for Clinical Laboratory Standards) guidelines 
[24]. 
3.2.1.2. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) 
The MIC and MBC were determined in MHB using the broth microdilution method in 96-well 
polystyrene microtitre plates (Eppendorf, Hamburg, Germany) according to the NCCLS guidelines. 
The results obtained were confirmed using the alamarBlue® (AB) (Thermo Fisher Scientific, Waltham, 
MA, USA) planktonic susceptibility assay [25]. Hemp EO was prepared as 10% (v/v) solutions in 
ethanol and used in the range of 0.5–16 mg/mL; naringenin was solubilized in dimethyl sulfoxide 
(DMSO) and used in the range of 64–1024 µg/mL, while the bacterial concentration was 1.0 × 105 
CFU/mL. The plates were incubated at 37 °C for 24 h. 
The MIC was defined as the lowest concentration without visible growth. The MBC was defined 
as the lowest concentration that induced a reduction in CFU corresponding to 99.9% compared to the 
initial inoculum, and was determined by spreading on MHA with 100 µL of sample taken by the 
wells corresponding to the MIC. Controls consisting of (i) S. aureus broth cultures in MHB without 
the addition of the sample, (ii) MHB with the test sample at different concentrations, (iii) MHB plus 
10% ethanol, and (iv) just MHB were also inserted in the experiments. Three independent 
experiments were performed in triplicate. 
3.2.1.3. AB Planktonic Susceptibility Assay 
The experiments were carried out as previously described in Section 3.2.1.2. After the incubation 
of the plates at 37 °C for 24 h, 10× alamarBlue® (AB) cell viability reagent was added to the treated 
and untreated broth cultures to assess the viability of bacterial cells. The plates were incubated at 37 
°C for 1–4 h. The absorbance was then read at 570 nm (A570) and 600 nm (A600) on a plate reader 
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(SpectraMax 190, Molecular Devices, San Jose, CA, USA). The percentage reduction of AB in the 
treated and non-treated samples was calculated using the formula indicated by the manufacturer. 
Controls consisting of (i) MHB with the test sample at different concentrations, (ii) MHB plus 10% 
ethanol, and (iii) just MHB were also inserted in the experiments. The AB MIC was defined as the 
lowest sample concentration resulting in ≤ 50% reduction of AB and a purplish/blue well 1 h after the 
addition of the AB as reported by Pettit et al. (2005) [25]. Three independent experiments were 
performed in triplicate. 
3.2.1.4. Determination of Minimum Biofilm Eradication Concentration 
The antibiofilm effect of each sample was determined by the evaluation of minimum biofilm 
eradication concentration (MBEC) [26]. The MBEC was defined as the lowest concentration which 
completely eradicated bacterial biofilm developed in 96-well flat-bottomed polystyrene microtiter 
plates. Briefly, S. aureus was grown in TSB overnight at 37 °C by shaking at 125 rpm. The overnight 
broth cultures were diluted to 1.0 × 105 CFU/mL in TSB supplemented with 1% (w/v) glucose. Two 
hundred microliters of the diluted broth cultures were inoculated into 96-well flat-bottomed 
polystyrene microtiter plates (Eppendorf, Hamburg, Germany) and incubated at 37 °C for 24 h under 
static conditions. At the end of incubation, the biofilms were rinsed in phosphate-buffered saline 
(PBS) and the test sample was added to the pre-formed biofilms at concentrations corresponding to 
2 × MIC, 3 × MIC, and 4 × MIC of each test sample. Controls consisting of (i) S. aureus biofilms without 
the addition of the sample, (ii) TSB plus 1% (w/v) glucose with the sample, (iii) TSB plus 1% (w/v) 
glucose plus 10% ethanol, and (iv) just TSB plus 1% (w/v) glucose were inserted in the experiments. 
The plates were then incubated at 37 °C for 24 h under static conditions. The inhibitory effect was 
measured using AB assay, crystal violet (CV) staining, and CFU counts. Three independent 
experiments were performed in quadruplicate. 
3.2.1.5. AB Biofilm Eradication Assay 
After the treatment with the test sample, the biofilms were rinsed with PBS, and AB was added 
following the manufacturer’s instructions. The plates were incubated for 1–4 h at 37 °C. The 
absorbance was read and the percentage reduction of AB in the treated and non-treated samples was 
calculated using the formula indicated by the manufacturer. The AB MBEC was defined as the lowest 
concentration of the test sample resulting in ≤ 50% reduction of AB and a purplish/blue well 1 h after 
the addition of the AB. Three independent experiments were performed in quadruplicate. 
3.2.1.6. Biofilm Eradication Evaluation by Crystal Violet Assay and Live/Dead Cell Viability 
Staining 
The treated and non-treated biofilms were washed with PBS and then dried. Biofilms were 
stained with 200 µL of 0.5% Gram’s crystal violet and then rinsed with PBS and dried. The biofilm 
biomass was quantified by destaining the biofilms for 10 min with 33% acetic acid (by volume) and 
by measuring the absorbance at 590 nm [27]. With regards to the live/dead assay, S. aureus biofilms 
were grown and treated as previously described. The biofilms, treated with 24 mg/mL hemp EO or 
2048 µg/mL of naringenin, and the corresponding non-treated controls were rinsed with PBS and 
stained with a BacLight kit (Thermo Fisher Scientific, Waltham, MA, USA). The analysis was 
performed using a Leica DMR Fluorescent Microscope (Leica microsystem, Wetzlar, Germany). 
Three experiments were performed in duplicate. 
3.2.1.7. Cell Viability Evaluation through Colony-Forming Unit Count 
Colony-forming unit (CFU) enumeration was performed to evaluate bacterial cell viability in the 
biofilm and planktonic phases. One hundred microliters of sample solutions taken from the MIC and 
MBEC wells, as well as from the two wells before and after the MIC and MBEC wells, were used for 
CFU counts. Serial dilutions of the stock were performed in PBS (pH 7.2) and plated on MHA at 37 
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°C for 18–24 h. The same evaluation was performed in the case of the AB assay because of its non-
toxic nature. 
3.2.2. Helicobacter pylori 
3.2.2.1. Bacterial Strains and Culture Conditions 
Fourteen clinical strains of H. pylori, with different antibiotic susceptibility patterns, isolated 
from patients with duodenal ulcer or gastritis, were used for this study. In particular, three strains 
highly resistant to metronidazole (MNZ; MIC > 8 µg/mL), four resistant to clarithromycin (CLR; MIC 
> 0.5 µg/mL), four resistant to both MNZ and CLR, and three susceptible to CLR, MNZ, and 
amoxicillin (AMX) (MIC ≤ 0.125 µg/mL), on the basis of the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) breakpoints were classified. A reference strain of H. pylori (ATCC 
43629) was used as the control. The strains were maintained at −80 °C in Wilkins–Chalgren broth 
(Difco, BD, San Jose, CA, USA) with 10% (v/v) horse serum (Seromed, Biocrhom, Germany) and 20% 
(v/v) glycerol (Merck, Darmstadt, Germany) until required for experiments. Before being used, the 
strains were subcultured twice on Columbia agar base (Difco, BD, San Jose, CA, USA) supplemented 
with 10% horse serum and 0.25% bacto yeast extract (Difco, BD, San Jose, CA, USA). Plates were 
incubated for 72 h at 37 °C in an atmosphere of 10% CO2 in a gas incubator. 
3.2.2.2. Minimum Inhibitory Concentration and Minimum Bactericidal Concentration 
Determination 
MICs for Hemp EO and naringenin were determined using a modified broth dilution method 
as previously described [28]. Briefly, two-fold serial dilutions of the test samples were prepared in a 
96-well microtiter plate containing 100 µL of MegaCell™ Roswell Park Memorial Institute (RPMI-
1640) medium (Sigma-Aldrich, ST Louis, MO, USA) with 3% fetal calf serum (FCS). An inoculum 
equivalent to one McFarland standard was prepared in Wilkins–Chalgren broth and diluted in 
MegaCell™ RPMI-1640 medium with 3% FCS. Each well was inoculated with H. pylori at a final 
concentration of approximately 5 × 105 CFU/well. The plates were incubated at 37 °C under 
microaerophilic conditions (10% CO2 in a gas incubator) and examined after 72 h of incubation. For 
the MBC, aliquots (10 µL) of suspensions without visible growth were spotted on Columbia agar 
plates and incubated at 37 °C for 3–5 days under microaerophilic conditions. 
3.2.3. Candida and Malassezia Strain Growth Inhibition 
Hemp EO was tested against four clinical isolates of Candida spp. (Candida albicans CO23, C. 
glabrata DSY 562, C. krusei 45709, and C. tropicalis 47829) and four clinical isolates of Malassezia spp. 
including M. furfur 188 and 180, M. globosa 130, and M. sympodialis 855. Candida strains were cultured 
in Sabouraud dextrose agar (SDA) at 30–37 °C with aeration for 24 h. Malassezia isolates were sub-
cultured at 32 ± 2 °C for 72 h on liquid Leeming–Notman medium modified (1% peptone, 0.5% 
glucose, 0.01% yeast extract, 0.4% ox-bile, 0.2% glycerol, 1% whole cow's milk, and 0.05% Tween 20). 
MIC was determined using the microbroth dilution method according to the NCCLS [29] for Candida 
strains and modified to support growth of lipid-dependent yeasts [30] for Malassezia strains. Solutions 
of hemp EO (100 mg/mL) were prepared in RPMI-1640 supplemented with Tween 80 (final 
concentration of 0.001% v/v). Briefly, to determine the MIC of EO for Candida strains, RPMI-1640 
supplemented with 3-(N-morpholino)propanesulfonic acid (MOPS) at pH 7 was used. For Malassezia 
spp., the RPMI-1640 medium was supplemented with glucose (1.8%), peptone (1%), ox-bile (0.5%), 
malt extract (0.5%), Tween 20 (0.5%), Tween 80 (0.05%), and glycerol (1%). The dilution, ranging from 
12 to 12480 µg/mL of EO, was prepared in 96-well plates. The inoculum size was about 2.5 × 103 
cells/mL. The plates were incubated at 30 °C for 48 h or at 32 °C for 72 h for Candida spp. and Malassezia 
spp., respectively. 
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3.3. Cytotoxicity 
3.3.1. Cell Lines 
The human estrogen-dependent (MCF-7) and triple-negative breast cancer (MDA-MB-468) cell 
lines were kindly provided by Prof. Eufemi (Dept. of Biochemical Science Rossi Fanelli, Sapienza 
University of Rome, Italy), while colorectal adenocarcinoma (Caco-2) cells were obtained from ATCC 
(American Type Culture Collection; Manassas, VA, USA). Furthermore, the extrahepatic 
cholangiocarcinoma cell line (Mz-ChA-1) from human gallbladder along with nonmalignant, 
immortalized cholangiocytes (H69) were kindly gifted by Prof. G. Alpini (Texas A&M University, 
Temple, TX, USA). MCF7, MDA-MB-468, and Caco-2 cells were grown at 37 °C in 5% CO2 in 
Dulbecco’s modified Eagle’s medium, supplemented with sodium pyruvate (1%), fetal bovine serum 
(10% v/v), glutamine (2 mM), streptomycin (100 µg/mL), and penicillin (100 U/mL). Mz-ChA-1 cells 
were maintained at 37 °C in a 5% CO2 incubator in Connaught Medical Research Laboratories 1066 
medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin, gentamycin, and 
streptomycin, and 2 mM glutamine. At last, the nonmalignant cholangiocytes H69 were cultured in 
Dulbecco’s modified Eagle’s medium/Nutrient Mixture F-12 Ham (3:1), supplemented with 1% 
penicillin and streptomycin, plus the following: 1.8 × 10−4 M adenine, 5 µg/mL insulin, 5 µg/mL 
transferrin, 2 × 10−9 M triiodothyronine, 1.1 × 10−6 M hydrocortisone, 5.5 × 10−6 M epinephrine, 1.64 × 
10−6 M epidermal growth factor, and 10% FBS [31]. All experiments were performed when cells 
reached the logarithmic growth phase. 
3.3.2. Treatment Protocol 
The cultured cells were seeded into 96-well microplates (20,000 cells/well), allowed to grow for 
24 h, then treated with the hemp EO for a further 24 h. To perform the assay, progressive dilutions of 
the hemp EO in ethanol (EtOH; 100% v/v) were prepared, then assessed at 1% v/v in the cell medium. 
3.3.3. Cytotoxicity Assay 
After 24-h incubation, the cytotoxicity of the treatment was measured using the 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay according to previously 
published methods [32]. The assay was carried out three times and, in each experiment, each 
concentration was tested almost in triplicate. Cell viability was determined as follows: ((OD treated 
cells − OD medium control)/(OD untreated cells − OD medium control)) × 100. 
3.4. Enzyme Inhibitory Activity 
The enzyme inhibitory activities of the extracts were calculated as equivalents of the 
corresponding standard drug per gram of the sample (i.e., galantamine for acetylcholinesterase 
(AChE) and butyrylcholinesterase (BChE), kojic acid for tyrosinase, orlistat for lipase, and acarbose 
for α-amylase and α-glucosidase inhibition assays). 
3.4.1. Cholinesterase Inhibition 
Test solution (50 µL) was mixed with 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB; 125 µL) and 
enzyme solution (AChE or BChE) solution (25 µL) in Tris-HCl buffer (pH 8.0) in a 96-well microplate 
and incubated for 15 min at room temperature. The reaction was then initiated with the addition of 
the corresponding substrates (acetylthiocholine iodide (ATCI) or butyrylthiocholine chloride (BTCl), 
25 µL). Similarly, a blank was prepared without the enzyme (AChE or BChE) solution. The 
absorbances of sample and blank were noted at 405 nm after 10-min incubation at 25 C. Results are 
expressed as milligrams of galantamine equivalent per gram of extract (GALAE/g extract) [22]. 
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3.4.2. α-Amylase Inhibition 
An aliquot of the test solution (25 µL) was mixed with α-amylase solution (50 µL) in phosphate 
buffer (pH 6.9 with 6 mM sodium chloride) in a 96-well microplate and incubated for 10 min at 37 
°C. The reaction was then initiated with the addition of starch solution (50 µL, 0.05%). Similarly, a 
blank was prepared without the enzyme. The reaction mixture was incubated 10 min at 37 °C, 
stopped with the addition of HCl (25 µL, 1 M), and then the iodine/potassium iodide solution was 
added (100 µL). The absorbances of sample and blank were calculated at 630 nm. The absorbance of 
the blank was subtracted from that of the sample. Results are expressed as millimoles of acarbose 
equivalent per gram of extract (ACAE/g extract) [33]. 
3.4.3. α-Glucosidase Inhibition 
Test solution (50 µL) was mixed with glutathione (50 µL), α-glucosidase solution (50 µL) in 
phosphate buffer (pH 6.8), and p-nitrophenyl-β-D-glucuronide (PNPG; 50 µL) in a 96-well microplate 
and incubated for 15 min at 37 °C. Similarly, a blank was prepared without the enzyme solution. The 
reaction was stopped with sodium carbonate (50 µL, 0.2 M) and the absorbances of sample and blank 
were noted at 400 nm. Results are expressed as millimoles of acarbose equivalent per gram of extract 
(ACAE/g extract) [33]. 
3.4.4. Tyrosinase Inhibition 
Test solution (25 µL) was mixed with tyrosinase solution (40 µL) and phosphate buffer (100 µL, 
pH 6.8) in a 96-well microplate and incubated for 15 min at 25 °C. The reaction was then initiated 
with L-3,4-dihydroxyphenylalanine (L-DOPA; 40 µL). Similarly, a blank was prepared (without the 
enzyme solution). The absorbances of sample and blank were recorded at 492 nm after 10-min 
incubation at the room temperature. Results are expressed as milligrams of kojic acid equivalent per 
gram of extract (KAE/g extract) [34]. 
3.4.5. Lipase Inhibition 
Porcine pancreatic lipase (type-II) activity was performed using p-nitrophenyl butyrate (p-NPB) 
as a substrate [35]. The enzyme solution (1 mg/mL) was prepared in 50 mM Tris-HCl (pH 8.0). An 
aliquot of 25 µL was mixed with a lipase solution (50 µL) in a 96-well microplate and incubated for 
20 min at 25 °C. The reaction was initiated with the addition of p-NPB (5 mM, 50 µL). Similarly, a 
blank sample (prepared in the same manner but without the extract) was prepared and analyzed 
according to this procedure. Results are expressed as milligrams of orlistat equivalent per gram of 
extract (OE/g extract). 
3.5. G. mellonella Injection Procedure 
Ten larvae (250–320 mg each) of Galleria mellonella were selected at random for each step in the 
procedure. Different concentrations from 0.78 to 6.25 mg/mL hemp EO in PBS buffer added with 
0.01% Tween 20 were injected into the hemocoel through the last left proleg (Hamilton syringe 701N; 
volume, 10 µL; needle size, 26 s; cone tip; Sigma-Aldrich, Milan, Italy) [36]. After injection, larvae 
were incubated in petri dishes at 37 °C in standard aerobic conditions and survival was recorded at 
24-h intervals for five days. Larvae were considered dead when they displayed no movement in 
response to gentle prodding with a pipette tip. Studies included one group that did not receive 
injection and one group that was injected with PBS plus 0.01% Tween 20 as a control. Each experiment 
was repeated three times. 
3.6. Statistical Analysis 
The statistical significance of difference between controls and experimental groups for the 
antimicrobial activity was evaluated using Student’s t-test. Results of the anti-proliferative activity 
were expressed as means ± standard error of the mean (SEM). Statistical analysis was performed 
Molecules 2018, 23, 3266 11 of 26 
 
using GraphPad Prism™ (Version 5.00) software (GraphPad Software, San Diego, CA, USA). The 
one-way analysis of variance (one-way ANOVA), followed by Dunnett’s multiple comparison post 
hoc test, was used to verify the significance level of a response with respect to the vehicle control. A 
p-value < 0.05 was considered as statistically significant. 
4. Results and Discussion 
The hemp crop produced approximatively 10,000–12,000 kg/ha of fresh biomass. The hydro-
distillation of flowering aerial parts gave 0.28% essential oil yield (mL/kg fresh weight), expressed as 
the mean value of separate distillations from 2 kg of fresh weight each. Minimum and maximum 
ranges of EO were 0.19% and 0.31%, respectively. The highest yield value was obtained in the early-
September distillation, while the lowest was from the late-September/early-October collection (full 
blooming plants) (Figure S1, Supplementary Materials). As expected, the difference in EO yield was 
not evident in day-by-day analysis, while there was a significant difference (* p ˂ 0.05) in the data 
comparison between the collections on the first and last days (0.29 ± 0.02% and 0.19 ± 0.01% mean 
yield ± SEM, 1 September and 2 October, respectively). The trend of yield variation was also evident 
upon analyzing data grouped by decades, confirming the early collection as the preferable practice 
for optimal yield (0.29 ± 0.004%, 0.25 ± 0.005%, and 0.21 ± 0.003% mean yield ± SEM; 1–11 September, 
12–22 September, and 23 September–2 October, respectively (ANOVA, p < 0.0001; *** p < 0.001). The 
quantitative production of hemp EO was monitored for one month. Fresh plant material was 
collected daily, manually selecting plants only in full bloom, and three or four separated distillations 
were immediately performed. Experimental data confirm that plant harvest is preferable at the early 
flowering stage due to the evident reduction in EO content in proximity to fruiting. From the weekly 
data analysis, the reduction (−30%) of EO production was evident in late flowering stages, while all 
yield data within the same week were more homogenous. At the end of the production process, all 
collected hemp EO samples were pooled to provide a single batch available for the market and for 
the successive analyses. The aromatic water, separated from the EO but enriched by fragrant 
molecules, was further investigated for its chemical composition, antioxidant activity, color 
characteristics, and enzyme inhibitory activity with the aim of giving value to this important by-
product. 
4.1. Phytochemical Analyses 
4.1.1. Color Analysis 
The tristimulus colorimetry was not yet reported in the literature to evaluate the color properties 
of hemp EO and its aromatic water. The EO, obtained from the fresh inflorescences via steam 
distillation and separated by water, mainly contains a mixture of monoterpene and sesquiterpene 
hydrocarbons. Our analyses, as subsequently described, account for twelve components belonging 
to this class, in which (E)-caryophyllene and caryophyllene oxide represent the principal impact 
compounds. As a counterpart in the aromatic water, a polyphenolic fraction mainly represented by 
catechins and phenolic acids was found. The color of the EO, which could vary between pale yellow 
and light green was found to show a significant yellow parameter (b*) along with a weak green value 
(a*), which, together with the quite bright L* value, account for the light yellow-green nuance 
characterizing our sample. The aromatic water showed a very clear yellow color associated with a 
relatively high L* value and particularly low a* and b* parameters. If this is related to the catechin 
content, the more intense yellow-green color of the separated oil could be maybe attributed to other 
pigments, weakly represented but intensely colored, such as chlorophylls, carotenoids, or others [37]. 
The colorimetric data, complete with standard deviations, are reported in Table 1, and the reflectance 
curves are shown in Figure 1. 
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Table 1. Colorimetric data of hemp essential oil (EO) and its aromatic water. 
CIELAB Parameters * 
Hemp Essential Oil 
Mean Value ± SD 
Aromatic Water 
Mean Value ± SD 
L* 57.26 ± 1.66 60.46 ± 2.54 
a* −5.68 ± 0.33 −1.22 ± 0.15 
b* 24.36 ± 1.63 2.23 ± 0.24 
C*ab 25.01 ± 1.66 2.54 ± 0.28 
hab 103.13 ± 0.11 118.66 ± 0.72 
* CIELAB parameters (L*, a*, b*, C*ab and hab) are defined as follows: L* defines the lightness and varies 
between 0 (absolute black) and 100 (absolute white), a* measures the greenness (−a*) or the redness 
(+a*) and b* measures the blueness (−b*) and the yellowness (+b*). C*ab (chroma, saturation) expresses 
a measure of color intensity and hab (hue, color angle) is the attribute of appearance by which a color 
is identified according to its resemblance to red, yellow, green, or blue, or a combination of two of 
these attributes in sequence. 
 
Figure 1. Reflectance curves of hemp essential oil (EO; gray) and its aromatic water (yellow). 
4.1.2. GC Flame Ionization Detector Analysis of the Tetrahydrocannabinol (THC) Content 
The THC content was routinely checked on C. sativa var. Futura 75 aerial parts and on the 
processed final product (hemp EO) and was found to be below the limits of Italian government law 
(THC < 0.2%). 
4.1.3. GC/MS Analysis of the Volatile Components of the EO 
The GC/MS analysis of hemp EO exhibited several peaks that were related to different classes of 
phytochemicals. The most abundant components belonged to the class of sesquiterpenes and 
sesquiterpenoids (28% (E)-caryophyllene, 4% trans-α-bergamotene, 13% humulene, 7% α- and β-
selinene, and 15% caryophyllene oxide) representing about 67% of the total composition (Table 2). 
Monoterpenoids were also present in an appreciable amount (11% total pinene fraction and 11% β-
myrcene), together with lower-abundance components ranging from 6% (α-terpinolene) to 2% (D-
limonene). 
Table 2. Phytochemicals identified by GC/MS analysis of hemp EO. 
Compound Area % KI b KIlit c 
α-Pinene a 8 936 936 
β-Pinene 3 975 978 
β-Myrcene a 11 984 987 
D-Limonene a 2 1030 1027 
β-Ocimene 3 1051 1050 
α-Terpinolene 6 1089 1084 
(E)-Caryophyllene a 28 1427 1427 
trans-α-Bergamotene 4 1439 1437 
Humulene 13 1459 1459 
β-Selinene 4 1492 1486 
α-Selinene 3 1500 1497 
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a Standards available from commercial sources were injected to further confirm the assignment. b The 
Kovats index (KI) values were experimentally measured using n-alkanes mixtures (C8–C24) on the 
HP-5MS column. c Literature values. 
4.1.4. Total Phenolic, Flavonoid, and Phenolic Acid Content 
The amounts of total bioactive compounds in the aromatic water were detected by colorimetric 
methods, and the results are summarized in Table 3 (hemp EO was not soluble in the assay reagents). 
Total phenolics, flavonoids, and phenolic acids were found to be 28.04 mg GAE/g, 4.04 mg RE/g, and 
1.76 mg CE/g extract, respectively. Apparently, the total amount of flavonoids and phenolic acids 
was approximately 20% of total phenolics. Several researchers reported different levels of total 
bioactive compounds in Cannabis sativa extracts [38–42] and, generally, the extracts were found to be 
rich sources of these compounds. These differences in the literature may also be linked to 
geographical and climatic conditions, or genetic structures. 
Table 3. Total bioactive compounds in Cannabis sativa extract samples. 
Test 
Sample 
Total Phenolic Content (mg 
GAE/g Extract) * 
Total Flavonoid Content 
(mg RE/g Extract) * 
Total Phenolic Acid Content 
(mg CE/g Extract) * 
Hemp EO nt nt nt 
Aromatic 
water 
28.04 ± 0.23 4.04 ± 0.03 1.76 ± 0.14 
* Values expressed are means  SD of three parallel measurements. GAE: gallic acid equivalent; RE: 
rutin equivalent; CE: caffeic acid equivalent; nt: not tested due to solubility issues. 
4.1.5. HPLC-PDA Analysis of the Phenolic Fraction 
Both hemp EO and its aromatic water, studied for the presence of the most important 22 
phenolics, displayed an interesting profile in terms of richness and metabolite-oriented amount 
(Table 4) [43]. 
Naringenin (706 µg/mL) and its glycosylated derivative naringin (83 µg/mL) emerged, among 
the ones studied, as the two most important metabolites which could further characterize this EO, 
along with the presence of catechin (60 µg/mL) and epicatechin (56 µg/mL) (see Supplementary 
Materials for the chromatogram of a real sample). Considering the mean concentration of naringenin, 
hemp EO seems to be relevant as a source of this important flavanone for cosmetic and 
pharmaceutical purposes. Moreover, naringenin was shown to act as an antioxidant, anti-
inflammatory, anti-cancer, anti-diabetic, and anti-obesity agent [44]. Other compounds such as 
benzoic acid, 2,3-dimethoxybenzoic acid, and syringic acid were also detected in discrete quantities. 
Conversely, the number and the relative amounts of these phytochemicals were scarcely found in the 
aromatic water (rich in catechin), despite the unique presence of a small percentage of rutin (0.18 
µg/mL). Chlorogenic acid, vanillic acid, 3-hydroxy-4-methoxybenzaldehyde, p-coumaric acid, 
sinapinic acid, o-coumaric acid, harpagoside, t-cinnamic acid, and carvacrol were absent in this EO 
and in its aromatic water. 
Table 4. Quantitative (µg/mL) * multicomponent phenolic pattern in test samples. 
Compound Hemp EO Aromatic Water 
Gallic acid 0.23 ± 0.03 0.62 ± 0.08 
Catechin 60 ± 4 7.5 ± 0.2 
p-OH Benzoic acid 0.35 ± 0.02  
Epicatechin 56 ± 5  
Syringic acid 7.8 ± 1.3  
3-OH Benzoic acid 4.6 ± 0.4  
Rutin  0.18 ± 0.03 
t-Ferulic acid 0.37 ± 0.04  
Naringin 83 ± 15 0.63 ± 0.09 
2,3-DiMeO benzoic acid 10.4 ± 0.3  
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Benzoic acid 31.9 ± 0.9  
Quercetin 1.7 ± 0.1  
Naringenin 706 ± 62 0.16 ± 0.02 
Total 962.35 9.09 
* Data reported are means ± SD from three independent determinations. 
4.2. Antioxidant Properties 
Antioxidative effects of natural products could be considered as a first insight in detecting their 
ethnopharmacological relevance and potential. To this end, a certain antioxidant profile could be 
provided by comparing different chemical assays representative of alternative mechanisms. For this 
reason, the antioxidant ability of C. sativa samples was evaluated using six complementary in vitro 
tests: free-radical scavenging (DPPH and ABTS), reducing power (CUPRAC and FRAP), 
phosphomolybdenum, and metal chelating assays. The results are tabulated in Table 5. The aromatic 
water exhibited stronger free-radical scavenging and ferric reducing potential when compared to the 
EO. In addition, the EO was not active on ABTS radicals. However, the best activity in 
phosphomolybdenum and metal chelating assays was obtained by the EO. These findings may be 
linked to the presence of a large amount of naringenin and catechin, which act as good chelators 
[45,46]. Also, the phosphomolybdenum assay is known as a total antioxidant test, and different 
phytochemicals, including vitamin C, tocopherol, or carotenoids, may be active in this assay. 
CUPRAC and FRAP tests showed good results with these products, which, along with metal 
chelating activity, could account for the potential of hemp EO in limiting the generation and the 
accumulation of harmful free radicals via the Fenton reaction. Similarly, some researchers 
[39,40,47,48] reported that C. sativa has great potential as a source of natural antioxidants for 
developing novel functional applications. 





















Hemp EO 35.12 ± 1.63 5.56 ± 0.42 na 141.15 ± 2.74 57.02 ± 0.69 19.27 ± 1.23 
Aromatic 
water 
1.42 ± 0.05 39.71 ± 1.54 103.38 ± 0.07 109.15 ± 1.78 82.93 ± 1.70 3.79 ± 0.25 
* Values expressed are means  SD of three parallel measurements. GAE: gallic acid equivalent; RE: 
rutin equivalent; CE: caffeic acid equivalent; TE: trolox equivalent; EDTAE: 
ethylenediaminetetraacetic acid (EDTA) equivalent; na: not active. 
4.3. Antimicrobial and Antibiofilm Activity of the Hemp EO versus Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive bacterium which permanently or transiently colonizes 
up to 60% of the human population and, for this reason, is also considered a component of the human 
microbiota [49]. S. aureus, however, is associated with nosocomial infections including those 
involving orthopedic implants [50], and may be responsible for many infections such as endocarditis, 
osteomyelitis, prostatitis, and infections of skin and soft tissue [51]. Its persistence and recalcitrance 
are due to the capability of S. aureus to develop biofilms as a complex structure formed by bacterial 
cells embedded in an extracellular polymeric substance (EPS), a mixture of macromolecules such as 
exopolysaccharides, proteins, and extracellular DNA. The EPS composition may differ with bacterial 
strain, culture conditions, and biofilm age. Biofilm formation guarantees antibiotic tolerance and 
protection from the host immune system, making microbial biofilms difficult to eradicate [52]. 
The inhibitory effect of hemp EO against Gram-positive opportunistic/pathogenic 
microorganisms such as Clostridium spp. and Enterococcus spp. was demonstrated [5], suggesting its 
use against nosocomial, spoilage, and food-borne pathogens. In our paper, the antimicrobial and 
antibiofilm effects of hemp EO were evaluated against five S. aureus strains, one reference and four 
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clinical strains, isolated from different areas of the body and also characterized by a different 
antimicrobial susceptibility pattern (Table 6; Table S1, Supplementary Materials). 
Table 6. The evaluation of the minimum inhibitory concentration (MIC), minimum bactericidal 
concentration (MBC), and minimum biofilm eradication concentration (MBEC) of the hemp EO 
against Staphylococcus aureus. Data are presented as the mean of three replicates of three independent 
experiments. ATCC—American Type Culture Collection. 








S. aureus ATCC 29213 Wound 8 16 2 24 
S. aureus 101 
Vaginal swab of a 
pregnant woman 
8 16 2 24 
S. aureus 104 
Pharyngeal swab of a 
male patient 
8 16 2 24 
S. aureus 105 
Urinary specimen of a 
male patient 
8 16 2 16 
The hemp EO showed MIC values corresponding to 8 mg/mL versus all S. aureus strains, 
including S. aureus 104, a multi-drug resistant strain isolated from a pharyngeal swab of a male 
patient (Table 6). With regards to MBC, the hemp EO was shown to be effective at 16 mg/mL versus 
all S. aureus strains (Table 6). The results obtained were confirmed using the AB reduction assay 
(Figures 2A,B). 
 
Figure 2. The evaluation of minimum inhibitory concentration (MIC) of the hemp EO versus 
Staphylococcus aureus determined using the alamarBlue® (AB) assay. (A) Representative image of 
colorimetric MIC determination using AB at 24 h of incubation. The white rectangle indicates the 
MICs at 8 mg/mL S. aureus 101. (B) The plot shows the percentage reduction of AB in the S. aureus 
broth cultures at different hemp EO concentrations compared to the corresponding untreated samples 
(0) evaluated as indicated in the experimental section of this manuscript. MHB: Mueller–Hinton 
broth; EtOH: ethanol. Data are presented as the mean of three replicates of three independent 
experiments. 
Furthermore, the hemp EO showed its capability to eradicate a mature biofilm developed by S. 
aureus; specifically, the minimum biofilm eradication concentration (MBEC) was determined using 
the AB assay, CV staining, CFU counting, and live/dead staining, followed by fluorescent microscopy 
analysis. The Hemp EO displayed an MBEC value of 24 mg/mL toward all strains of S. aureus except 
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for S. aureus 105, which showed an MBEC value corresponding to 16 mg/mL (Table 6 and Figures 
3A,B). The effect of the hemp EO on the eradication of S. aureus pre-formed biofilms was confirmed 
by the statistically significant reduction in CFU count, as shown in Figure 3C. The live/dead staining 
and fluorescent microscopy evaluation showed a well-structured biofilm constituting a great amount 
of live cells, as indicated by the green fluorescence (Figure 3D(a)). On the contrary, S. aureus mature 
biofilms treated with 24 mg/mL hemp EO did not show a reduction in biofilm biomass, as confirmed 
by the CV staining (data not shown); however, the biofilms treated with hemp EO were characterized 
by a multitude of dead cells as indicated by the red fluorescence (Figure 3D(b)). As mentioned above, 
the CV staining did not display any differences between the biomasses of treated and untreated 
biofilms (data not shown). 
 
Figure 3. The evaluation of minimum biofilm eradication concentration (MBEC) of the hemp EO 
versus Staphylococcus aureus biofilm determined using the AB assay, live/dead staining, and 
fluorescent microscopy analysis and colony-forming unit (CFU) counts. (A) Representative image of 
colorimetric MBEC determination using AB. The white rectangles indicate the MBECs at 24 mg/mL 
S. aureus 105. (B) The plot shows the percent reduction of AB in the S. aureus broth cultures at different 
hemp EO concentrations compared to the corresponding untreated samples (0) evaluated as indicated 
in Section 2. (C) CFU count of treated and untreated S. aureus biofilms. (D) Representative image of 
S. aureus (a) untreated and (b) treated biofilms with 24 mg/mL hemp EO. The biofilms were stained 
with a live/dead kit and visualized using fluorescent microscopy. The green fluorescence indicates 
live cells, whereas the red fluorescence indicates dead cells or cells with a compromised cell wall. TSB: 
tryptic soy broth; GLU: glucose. Data are presented as the mean of three replicates of three 
independent experiments; * p ˂ 0.05 vs. the controls (0). 
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Due to the high amount of naringenin in this EO, we aimed to evaluate the impact of this 
secondary metabolite on the antimicrobial activity. We also studied the MIC, MBC, and MBEC of 
naringenin against S. aureus 105. The data indicated an MIC of 512 µg/mL and an MBEC 
corresponding to 2048 µg/mL. The results demonstrated the antimicrobial and antibiofilm effects of 
naringenin contained in the hemp EO versus S. aureus. These results also confirmed the data of Yue 
et al. [53] who reported the effect of naringenin on the formation of the biofilm of Streptococcus mutans. 
The authors demonstrated that the MIC of naringenin was between 100 and 200 µg/mL, and that 200 
µg/mL naringenin was capable of inhibiting the biofilm formation after 4 and 24 h of incubation. 
Conversely, in the present study, we focalized the attention on the capability of naringenin to 
eradicate a mature biofilm developed by S. aureus after 24 h of incubation to evaluate an application 
of hemp EO in the treatment of pre-formed biofilms. 
Moreover, the antimicrobial effect of naringenin was also previously investigated on several 
bacterial species. In particular, the mechanism of action of naringenin was studied on Escherichia coli 
ATCC 25922 and S. aureus ATCC 6538. The authors demonstrated that the presence of naringenin 
induced modifications of cell-membrane fluidity, fatty-acid composition, and fatty-acid biosynthesis-
associated genes. Furthermore, the growth of S. aureus was significantly inhibited by low 
concentrations of naringenin [54,55]. 
4.4. Anti-Helicobacter Pylori Activity 
The antimicrobial potency of hemp EO and its main component naringenin was also explored 
against 14 H. pylori clinical isolates and the reference strain ATCC 43629, using the microdilution 
method at pH 7.5 [56]. As shown in Table 7, the activity of the two test samples was not related to the 
different antibiotic susceptibility of the strains; the EO showed an MIC50 of 32 µg/mL and an MIC90 
of 64 µg/mL, whereas naringenin showed an MIC50 of 16 µg/mL and an MIC90 of 32 µg/mL. By 
considering the strains resistant to the traditional antibiotics (MNZ and CLR), hemp EO was 2–4-fold 
more active than MNZ, and 4–16-fold more active than CLR. The potency of naringenin was 2–8- and 
4–16-fold higher than MNZ and CLR, respectively. MBC values were 64 µg/mL for hemp EO and 32 
µg/mL for naringenin. The MIC and MBC concentrations of all strains were the same for both 
compounds, except for the strains E34, 68, and F40/442, which had MBC values corresponding to two 
times the MIC. Because a drug is defined “bactericidal” when the MBC concentration does not exceed 
four-fold MIC value [57], we can conclude that hemp EO and naringenin have very good bactericidal 
effects (1 < MBC/MIC < 2). 
Table 7. Evaluation of the minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of hemp EO and naringenin against clinical Helicobacter pylori strains with 
different antimicrobial susceptibility patterns. 
H. Pylori 
Strains 






F4 16/16 16/16 MNZ 32; CLR > 256; AMX 0.064 
E34 16/32 16/16 MNZ 1; CLR 0.064; AMX 0.016 
Ro1 16/16 16/16 MNZ 1; CLR 64; AMX 0.016 
Ra2 16/16 16/16 MNZ 1; CLR 128; AMX 0.016 
E17 16/16 16/16 MNZ 2; CLR 256; AMX 0.064 
68 16/32 16/16 MNZ 32; CLR 0.0019; AMX 0.016 
ATCC 43629 8/8 16/16 MNZ 2; CLR 0.032; AMX 0.064 
23 32/32 32/32 MNZ 1; CLR 0.064; AMX 0.032 
Ro5 32/32 16/16 MNZ 128; CLR 16; AMX 0.125 
110R 64/64 16/16 MNZ 128; CLR 0.03; AMX 0.016 
F1 32/32 32/32 MNZ 2; CLR 4; AMX 0.064 
190 32/32 32/32 MNZ 1; CLR 0.032; AMX 0.032 
F40/499 32/32 16/16 MNZ 32; CLR 8; AMX 0.016 
F40/442 32/64 8/8 MNZ 64; CLR 0.015; AMX 0.015 
F34/497 64/64 16/16 MNZ 128; CLR 4; AMX 0.064 
MTZ = metronidazole; CLR = clarithromycin; AMX: amoxicillin. 
Molecules 2018, 23, 3266 18 of 26 
 
Nariman and coworkers [58] reported a study about the anti-Helicobacter pylori effect of C. sativa 
and other 19 plants extracts, collected from Iran areas. Of the 10 strains tested, six were defined 
susceptible by disc diffusion method. The MIC values of the 10 most effective extracts (C. sativa not 
included) against Helicobacter pylori ranged from 31.25 to 500 µg/mL. Following these studies and the 
threshold values reported by Kuete (2010) [59], our results demonstrate that hemp EO and naringenin 
have very good activity against H. pylori. Furthermore, it was reported that cannabidiol prevents 
intestinal inflammation damage induced by an alteration of cytokine levels [60]. Because the 
pathogenic effect of H. pylori infection is supposed to also be mediated by cytokine production of 
inflammatory cells present in the infected gastric mucosa [61], the antimicrobial activity of C. sativa 
extracts demonstrated in this study, associated with their anti-inflammatory effect, could represent a 
very interesting approach against Helicobacter pylori infection. 
4.5. Antifungal Activity of Hemp EO 
The antifungal activity of hemp EO against Candida spp. and Malassezia spp. was calculated as 
MIC value >12,460 µg/mL with no differences observed among Candida spp. and Malassezia spp. 
Hemp EO was not active against yeasts following the defined threshold activity values for plant 
extracts proposed as follows: MIC below 100 µg/mL (significant activity), 100 ≤ MIC ≤ 625 µg/mL 
(moderate activity), and MIC > 625 µg/mL (low activity) [59]. These results reinforced the selective 
antibacterial activity of hemp EO. 
4.6. Cytotoxicity 
To the best of our knowledge, the cytotoxicity of hemp EO in cancer cells is yet to be investigated. 
Under our experimental conditions, the hemp EO induced a statistically significant and 
concentration-dependent reduction of cancer cell viability, reaching almost a 75% inhibition of cell 
proliferation at the highest concentration of 250 µg/mL (Figure 4). A different anti-proliferative 
potency was found in the tested cell models, with Caco-2 and Mz-ChA-1 cells as the most sensitive 
biological systems. In fact, after 24 h of treatment with 50 µg/mL hemp EO, the cell viability was 
inhibited by about 66% in both cell lines (Figure 4). Accordingly, similar half maximal inhibitory 
concentration (IC50) values were calculated for Caco-2 and Mz-ChA-1 cells (Table 8). 
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Figure 4. Cytotoxic effect of hemp EO in different human cell lines after 24 h of exposure. MCF-7, 
estrogen-dependent breast cancer cells; MDA-MB-468, triple-negative breast cancer cells; Caco-2, 
colorectal adenocarcinoma cells; Mz-ChA-1, cholangiocarcinoma cells; H69, nonmalignant 
immortalized cholangiocytes. Data are the mean ± SEM from almost two independent experiments 
with three technical replicates (n = 6); * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. control determined by 
ANOVA followed by Dunnett’s multiple comparison post hoc test. 
Next, hemp EO significantly inhibited the growth of both breast cancer cell lines characterized 
by different biological features and heterogeneous susceptibility to anticancer agents, with more 
potency against MDA-MB-468 cells. In particular, the treatment with 50 and 75 µg/mL produced an 
inhibition of cell viability of 25% and 32% in MCF7 cells, and of 37% and 92% in MDA-MB-468 cells; 
90% proliferation inhibition was reached only at 100 µg/mL in MCF7 cells. As expected, the resulting 
IC50 value of the Hemp EO in MCF7 cells was about 1.6-fold higher than that obtained for MDA-MB-
468 cells, and almost threefold higher than that calculated for Caco-2 and Mz-ChA-1 cells. In contrast, 
slight cytotoxicity was produced in the nonmalignant cholangiocytes (H69), reaching a maximum of 
44% inhibition of cell proliferation at the highest concentration of 250 µg/mL; as a consequence, the 
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IC50 was not evaluable. On the basis of these results, the cytotoxicity of hemp EO appeared to be 
selective for cancer cells, particularly cholangiocarcinoma and coloncarcinoma, with a higher 
tolerability in normal cells. The cytotoxicity was similar to that of the positive control doxorubicin in 
Caco-2 and Mz-ChA-1 cells, while about 10-fold lower in breast cancer MCF7 and MDA-MB-468 cells 
(Table 8). Of note, this behavior suggests that hemp EO can affect specific cancer targets, which 
deserves to be deeply investigated. 
Table 8. Half maximal inhibitory concentration (IC50) values for the cytotoxicity of hemp EO in 
human cancer cells after 24 h of exposure. 
Cell Line 
Hemp EO Doxorubicin 
IC50 (CL) µg/mL 
MCF7 83.2 (72.7–95.2) 7.6 (4.5–12.9) 
MDA-MB-468 53.0 (44.2–64.3) 3.1 (2.1–4.6) 
Caco-2 28.7 (17.9–45.8) 23.3 (11.1–48.3) 
Mz-ChA-1 22.3 (8.3–42.5) 15.7 (6.0–31.5) 
H69 nd 13.7 (7.3–25.5) 
CL, confidential limits; nd, not determinable as the maximum cytotoxicity was 44.2% at the highest 
concentration tested (250 µg/mL). MCF-7, estrogen-dependent breast cancer cells; MDA-MB-468, 
triple-negative breast cancer cells; Caco-2, colorectal adenocarcinoma cells; Mz-ChA-1, 
cholangiocarcinoma cells; H69, nonmalignant immortalized cholangiocytes. 
Upon phytochemical analysis, several terpenoids, including monoterpenes and sesquiterpenes, 
along with flavonoids and tannins, were identified in this phytocomplex. Interestingly, α-pinene and 
β-caryophyllene exhibited high anti-proliferative activity on human erythroleukemic K562 cells [62]; 
moreover, β-caryophyllene and linalool exhibited interesting anti-proliferative activity on human 
amelanotic melanoma C32 cells and on renal cell adenocarcinoma cells [63]. β-Caryophyllene was 
also reported to possess chemopreventive properties and to interfere with liver cancer cell 
proliferation by inhibiting the activation of signal transducer and activator of transcription 3 (STAT3) 
signaling [64], whereas β-caryophyllene oxide was found to possess anti-proliferative activity, 
although at high concentrations, and chemosensitizing properties, thus restoring the sensitivity of 
resistant cancer cells to chemotherapy [65]. β-Myrcene was reported to possess anti-invasive 
properties in metastatic MDA-MB-231 human breast cancer cells through the inhibition of nuclear 
factor kappa B (NF-κB) activity [66]. D-Limonene is widely known to possess chemopreventive and 
antitumor properties; in a previous study, it induced tumor regression and cancer cell apoptosis, and 
inhibited inflammation and oxidative stress [67]. 
Among phenolics, naringin was reported to possess antitumor properties and to inhibit the 
growth of gastric cancer cells through the induction of autophagy [68]. The anti-proliferative and pro-
apoptotic activity of naringenin is also well documented [69,70]. This evidence suggests that several 
phytoconstituents can represent the possible bioactive agents of hemp EO, although the role of 
unique interactions of all the compounds in the phytocomplex cannot be excluded. 
4.7. Enzyme Inhibition 
Enzyme inhibitory effects of the tested C. sativa samples were investigated toward a panel of 
important enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α-amylase, 
α-glucosidase, tyrosinase, and lipase. The results are presented in Table 9. Generally, from the 
enzymatic standpoint, the highest values were observed in the EO, except for the lack of inhibitory 
effect on AChE and α-amylase. These variations observed can be explained by the different 
phytochemical compositions of the C. sativa samples. For example, the EO is richer in terms of volatile 
components, such as (E)-caryophyllene, caryophyllene oxide, and humulene, which are known as 
anti-tyrosinase agents [71]. Similarly, naringenin, the major compound in the EO, is very active on α-
glucosidase and pancreatic lipase [72,73]. In particular, lipase inhibition was the most promising 
effect after treatment with hemp EO. 
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In addition, the complex nature of phytochemicals or their interactions could be responsible for 
the observed inhibitory activities. Up to now, few studies were carried out on the enzyme inhibitory 
effect of C. sativa [42,74,75]. With this regard, the present study could provide a starting contribution 
for the scientific audience, and this plant may serve to prepare functional ingredients as a source of 
natural inhibitors. 






































na 3.40 ± 0.14 35.95 ± 3.19 na 3.77 ± 0.03 70.14 ± 2.40 
Aromatic 
water 
2.56 ± 0.02 3.48 ± 0.02 28.24 ± 1.94 0.10 ± 0.01 0.17 ± 0.04 na 
* Values expressed are the mean  SD of three parallel measurements. GALAE: galantamine 
equivalent; KAE: kojic acid equivalent; ACAE: acarbose equivalent; OE: orlistat equivalent; na: not 
active; AChE: acetylcholinesterase; BChE butyrylcholinesterase. 
4.8. In Vivo Toxicity Studies 
Larvae of Galleria mellonella are widely used as an invertebrate wax moth larva model to evaluate 
the virulence of microbial pathogens, measure the efficacy/safety of biologically active antimicrobial 
agents, and produce results comparable to those that can be obtained using mammals [76]. As a 
consequence, no ethical approval was required for this study because there was no use of mammal 
or animal models. In this work, the viability of G. mellonella larvae, to measure the relative toxicity of 
different concentrations of hemp EO, was evaluated over the study period of five days. As reported 
in Figure 5, no evident effects on survival were registered with 0.78 mg/mL hemp EO up to five days 
after treatment. The lethal dose (LD50) of Hemp EO was 1.56 mg/mL in the first 48 h of treatment, 
probably due to the lipophilic nature of the EO with respect to the larval biological fluids and the 
invasive administration procedure (Figure 5). 
 
Figure 5. Survival curves of Galleria mellonella larvae after hemp EO treatment. Each data point 
represents the percent survival of G. mellonella larvae (N = 10/group, repeated on three different 
occasions), following injection with test samples and incubation at 37 °C. Control larvae were not 
injected or injected with phosphate-buffered saline (PBS) plus Tween 20 to simulate the trauma 
associated with the administration. Larvae were monitored for 24 h up to five days. 
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The LD50 of 1.56 mg/mL was higher than the effective concentrations reported by us against H. 
pylori (8–64 µg/mL) and cell lines (22.3–250 µg/mL), but in the same range as those found active 
against S. aureus strains (8–24 mg/mL). In this case, the putative topical administration of the hemp 
EO to combat S. aureus wound infections guarantees a discrete safety index with respect to the 
parental administration in G. mellonella larvae. 
5. Conclusions 
The study of traditional crops could explain their ethnobotanical relevance by means of a deep 
analysis of the quali-quantitative phytochemical profile. We devoted our attention to the EO of the 
aerial parts of C. sativa var. Futura 75 cultivated in Italy, due to an increment in this crop’s cultivation. 
After the evaluation of tetrahydrocannabinol content, volatile fraction, phenolic and flavonoid 
pattern, and color parameters, we tested the EO of C. sativa aerial parts and its aromatic water against 
several targets of pharmaceutical interest (S. aureus, H. pylori, Candida and Malassezia spp., enzymes, 
and cancer cell lines), along with the preliminary evaluation of its safety toward a non-cancer cell line 
and G. mellonella larvae in vivo. In addition, due to the high content of naringenin, we further 
explored the inhibitory effects of this secondary metabolite against H. pylori and S. aureus to correlate 
the biological activity with the chemical composition. In particular, the antibacterial and antibiofilm 
activities of hemp EO suggested it could be a possible candidate for the treatment of infections related 
to those abovementioned microorganisms. Currently, reinvigorating the antimicrobial drug pipeline 
is mandatory, as increasingly resistant species continue to emerge or organize themselves in 
accessible communities. Secondary metabolites display drug-like and metabolite-like properties, 
acting synergistically with validated drugs, and possessing new mechanisms of action; nevertheless, 
the evaluation of their safety/tolerability is strongly requested. 
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